Zurich Cantonal Bank
INFI

Zurich Cantonal Bank’s Infinity Pharmaceuticals, Inc. INFI Stock Holding History

Zurich Cantonal Bank’s Portfolio INFI Stock Details INFI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-1,316
Closed -$2K – 2581
2016
Q3 		$2K Hold
1,316
– – ﹤0.01% 2552
2016
Q2 		$2K Hold
1,316
– – ﹤0.01% 2544
2016
Q1 		$7K Hold
1,316
– – ﹤0.01% 2472
2015
Q4 		$10K Hold
1,316
– – ﹤0.01% 2390
2015
Q3 		$11K Buy
+1,316
New +$12.1K ﹤0.01% 1929
2014
Q3 		– Sell
-17,000
Closed -$217K – 996
2014
Q2 		$217K Hold
17,000
– – 0.01% 833
2014
Q1 		$202K Sell
17,000
-33,000
-66% -$443K 0.01% 825
2013
Q4 		$691K Buy
+50,000
New +$706K 0.02% 563

Other funds holding INFI

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
PA
Pinnacle Associates New York $9.16B AUM 63.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Zurich Cantonal Bank's INFI Position: Q4 2016 in Review

Zurich Cantonal Bank sold out of Infinity Pharmaceuticals, Inc. (INFI) in Q4 2016, closing a stake of 1,316 shares — an estimated $2K sold.

Zurich Cantonal Bank first reported a position in INFI in Q4 2013 and held it in 8 quarters. The position peaked at $691K in Q4 2013. 94 funds tracked by Wall St. Rank hold INFI as of Q4 2016.

  • Zurich Cantonal Bank reported no remaining Infinity Pharmaceuticals, Inc. position as of Q4 2016 after selling out during the quarter.
  • Zurich Cantonal Bank sold 1,316 Infinity Pharmaceuticals, Inc. shares in Q4 2016, an estimated $2K.
  • Zurich Cantonal Bank first reported a position in Infinity Pharmaceuticals, Inc. in Q4 2013 and held it in 8 quarters.
  • Zurich Cantonal Bank's Infinity Pharmaceuticals, Inc. position peaked at $691K in Q4 2013.
  • 94 funds tracked by Wall St. Rank held Infinity Pharmaceuticals, Inc. as of Q4 2016.

Based on Zurich Cantonal Bank's 13F filing for Q4 2016, filed 10 Feb 2017.